Germany
Japan
United Kingdom
China
Antibodies
View as table Download
Rabbit Polyclonal Antibody against MEF2C (S387)
| Applications | IF, IHC, WB |
| Reactivities | Human |
| Conjugation | Unconjugated |
| Immunogen | This MEF2C antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 365-394 amino acids from human MEF2C. |
c-Myc (MYC) chicken polyclonal antibody, Aff - Purified
| Applications | ELISA, IF, IHC, IP, WB |
| Reactivities | Human |
| Immunogen | Synthetic peptide containing the Human c-myc epitope (i.e., EQKLISEEDL) conjugated to KLH. The first injection included complete Freund's adjuvant; subsequent injections included incomplete Freund's adjuvant. Eggs were collected after the fourth injection, and antibodies were purified from the yolks using a proprietary method that yields a purity of >90%. |
Rabbit Polyclonal Antibody against SOX2 (N-term)
| Applications | FC, IF, IHC, WB |
| Reactivities | Human |
| Conjugation | Unconjugated |
| Immunogen | This SOX2 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 89-119 amino acids from the N-terminal region of human SOX2. |
Rabbit Polyclonal Antibody against MDM2 (C-term)
| Applications | IHC, WB |
| Reactivities | Human, Mouse |
| Conjugation | Unconjugated |
| Immunogen | This Mdm2 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 393-424 amino acids from the C-terminal region of human Mdm2. |
c-Myc (MYC) chicken polyclonal antibody, FITC
| Applications | ELISA, IF, IHC, WB |
| Reactivities | Human |
| Conjugation | FITC |
| Immunogen | Synthetic peptide containing the Human c-myc epitope (i.e., EQKLISEEDL) conjugated to KLH. After repeated injections, immune eggs were collected, from which the IgY fractions were prepared. |
Rabbit Polyclonal Antibody against EIF4E2 (N-term)
| Applications | IHC, WB |
| Reactivities | Human |
| Conjugation | Unconjugated |
| Immunogen | This EIF4E2 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 12-41 amino acids from the N-terminal region of human EIF4E2. |
Rabbit Polyclonal Antibody against MYST2 (N-term)
| Applications | IHC, WB |
| Reactivities | Human |
| Conjugation | Unconjugated |
| Immunogen | This HBO1/MYST2 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 99-130 amino acids from the N-terminal region of human HBO1/MYST2. |
LHX6 (N-term) rabbit polyclonal antibody, Aff - Purified
| Applications | IHC, WB |
| Reactivities | Human, Mouse |
| Immunogen | KLH conjugated synthetic peptide between 36-65 amino acids from the N-terminal region of human Lhx6. |
Glutaredoxin 2 (GLRX2) (C-term) rabbit polyclonal antibody, Purified
| Applications | FC, IHC, WB |
| Reactivities | Human, Mouse |
| Immunogen | GLRX2 antibody is generated from Rabbits immunized with a KLH conjugated synthetic peptide between 126~155 amino acids from the C-terminal region of Human GLRX2. |
Rabbit Polyclonal Antibody against MYST2 (Center)
| Applications | IF, IHC, WB |
| Reactivities | Human |
| Conjugation | Unconjugated |
| Immunogen | This HBO1/MYST2 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 213-246 amino acids from the Central region of human HBO1/MYST2. |
Active filters
Category
-
Antibodies
- Primary Antibodies
Applications
- IHC
Isotypes
- Ig
Families
- Transcription Factors
Filter by
Target Symbol
- MYC (3)
- KAT7 (2)
- MEF2C (2)
- PIAS1 (2)
- SUMO1 (2)
- ATF6 (1)
- ATXN3 (1)
- BCL3 (1)
- BCLAF1 (1)
- BTG2 (1)
- CARM1 (1)
- CBY1 (1)
- CCNT1 (1)
- CDX2 (1)
- CTNNB1 (1)
- DEK (1)
- DRG1 (1)
- EIF4E2 (1)
- ELAVL2 (1)
- ERCC8 (1)
- ETS2 (1)
- EYA4 (1)
- FOSL2 (1)
- GLRX2 (1)
- HEXIM1 (1)
- HIPK1 (1)
- HOXA3 (1)
- HOXB6 (1)
- ID1 (1)
- ID4 (1)
- IKZF1 (1)
- KEAP1 (1)
- LHX6 (1)
- MAF1 (1)
- MBNL2 (1)
- MCM2 (1)
- MCM6 (1)
- MDM2 (1)
- MEF2A (1)
- MLXIP (1)
- MNDA (1)
- NFKBIL1 (1)
- NR0B2 (1)
- PAPOLA (1)
- PAX5 (1)
- PAX6 (1)
- PAX7 (1)
- PGR (1)
- PHB (1)
- PHF12 (1)
- PHF20 (1)
- POFUT1 (1)
- POLR1B (1)
- POLR2J (1)
- POU2F1 (1)
- PPP2CA (1)
- PTMA (1)
- RBM14 (1)
- RERE (1)
- RRAGC (1)
- SIM1 (1)
- SMURF2 (1)
- SOX2 (1)
- SP1 (1)
- TAF2 (1)
- TFB2M (1)
- TGFB1 (1)
- TIGD3 (1)
- TNFRSF1A (1)
- TP53 (1)
- TRIP13 (1)
- UBA52 (1)
- WT1 (1)
- ZNF180 (1)
- ZNF197 (1)
- ZNF30 (1)
- ZNF667 (1)
- ZNF720 (1)
Reactivities
Antibody Hosts
Clonalities
Conjugates
Pathways
- Pathways in cancer (9)
- TGF-beta signaling pathway (9)
- Cell cycle (8)
- MAPK signaling pathway (8)
- Chronic myeloid leukemia (6)
- Colorectal cancer (6)
- Small cell lung cancer (6)
- Ubiquitin mediated proteolysis (6)
- Wnt signaling pathway (6)
- Bladder cancer (5)
- Endometrial cancer (5)
- Jak-STAT signaling pathway (5)
- Thyroid cancer (5)
- Acute myeloid leukemia (3)
- ErbB signaling pathway (3)
- Huntington's disease (3)
- Prostate cancer (3)
- Alzheimer's disease (2)
- Amyotrophic lateral sclerosis (ALS) (2)
- Apoptosis (2)
- Basal cell carcinoma (2)
- Cytokine-cytokine receptor interaction (2)
- DNA replication (2)
- Endocytosis (2)
- Glioma (2)
- Melanoma (2)
- Metabolic pathways (2)
- Oocyte meiosis (2)
- Pancreatic cancer (2)
- Purine metabolism (2)
- Pyrimidine metabolism (2)
- RNA polymerase (2)
- Tight junction (2)
- p53 signaling pathway (2)
- Adherens junction (1)
- Adipocytokine signaling pathway (1)
- Allograft rejection (1)
- Antigen processing and presentation (1)
- Arrhythmogenic right ventricular cardiomyopathy (ARVC) (1)
- Autoimmune thyroid disease (1)
- Basal transcription factors (1)
- Cell adhesion molecules (CAMs) (1)
- Dilated cardiomyopathy (1)
- Dorso-ventral axis formation (1)
- Focal adhesion (1)
- Graft-versus-host disease (1)
- Hypertrophic cardiomyopathy (HCM) (1)
- Insulin signaling pathway (1)
- Leukocyte transendothelial migration (1)
- Long-term depression (1)
- Maturity onset diabetes of the young (1)
- Melanogenesis (1)
- Neurotrophin signaling pathway (1)
- Non-small cell lung cancer (1)
- Nucleotide excision repair (1)
- Pathogenic Escherichia coli infection (1)
- Progesterone-mediated oocyte maturation (1)
- RNA degradation (1)
- Renal cell carcinoma (1)
- Ribosome (1)
- Type I diabetes mellitus (1)
- Viral myocarditis (1)
- mTOR signaling pathway (1)